This inventor holds 1 USPTO granted patent and 1 published patent application, plus 2 CIPO patents. Top assignee: Arbutus Biopharma Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Petra Schreiner: Innovator in Lipid Nanoparticle Formulations
Introduction
Petra Schreiner is a notable inventor based in Burnaby, Canada. She has made significant contributions to the field of pharmaceutical formulations, particularly through her innovative work on lipid nanoparticles.
Latest Patents
Petra holds a patent for lipid nanoparticle formulations. This invention provides specific lipid nanoparticles that comprise one or more nucleic acid molecules, cholesterol, DSPC, PEG-C-DMA, and a cationic lipid. The lipid nanoparticles and pharmaceutical compositions are particularly useful for delivering nucleic acids such as siRNA or mRNA to patients or cells.
Career Highlights
Petra Schreiner is associated with Arbutus Biopharma Corporation, where she applies her expertise in developing advanced pharmaceutical solutions. Her work focuses on enhancing the delivery mechanisms for nucleic acids, which are crucial for various therapeutic applications.
Collaborations
Some of her notable coworkers include James Heyes and Adam Judge, who contribute to the innovative environment at Arbutus Biopharma Corporation.
Conclusion
Petra Schreiner's work in lipid nanoparticle formulations represents a significant advancement in the delivery of nucleic acids for therapeutic purposes. Her contributions continue to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile